Next Article in Journal
Let’s Talk about Thal: How Communication Can Improve Quality of Life
Previous Article in Journal
PIGI ZOIS: Pioneering with Credibility
 
 
Thalassemia Reports is published by MDPI from Volume 12 Issue 1 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Brief Report

Hepatitis C Virus Treatment Advances for Thalassaemia Patients

by
George Papatheodoridis
Professor in Medicine and Gastroenterology, Medical School of National and Kapodistrian University of Athens, Director of Academic Department of Gastroenterology, Laiko General Hospital, Athens, Greece
Thalass. Rep. 2018, 8(1), 7491; https://doi.org/10.4081/thal.2018.7491
Submission received: 10 April 2018 / Revised: 10 April 2018 / Accepted: 11 April 2018 / Published: 18 April 2018

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Chronic infection with hepatitis C virus (HCV) is a major problem for thalassaemia patients, as blood transfusions before 1990 were associated with a high risk of HCV infection [...]

Share and Cite

MDPI and ACS Style

Papatheodoridis, G. Hepatitis C Virus Treatment Advances for Thalassaemia Patients. Thalass. Rep. 2018, 8, 7491. https://doi.org/10.4081/thal.2018.7491

AMA Style

Papatheodoridis G. Hepatitis C Virus Treatment Advances for Thalassaemia Patients. Thalassemia Reports. 2018; 8(1):7491. https://doi.org/10.4081/thal.2018.7491

Chicago/Turabian Style

Papatheodoridis, George. 2018. "Hepatitis C Virus Treatment Advances for Thalassaemia Patients" Thalassemia Reports 8, no. 1: 7491. https://doi.org/10.4081/thal.2018.7491

Article Metrics

Back to TopTop